MeSH term
Frequency | Condition_Probility | Aged | 3 | 0.0 |
Case-Control Studies | 2 | 0.0 |
Comparative Study | 22 | 0.0 |
Female | 19 | 0.0 |
Humans | 137 | 0.0 |
Male | 16 | 0.0 |
Middle Aged | 11 | 0.0 |
Amino Acid Sequence | 90 | 0.0 |
Animals | 49 | 0.0 |
Cloning, Molecular | 15 | 0.0 |
Evolution, Molecular | 2 | 0.0 |
Gene Expression | 2 | 0.0 |
Models, Molecular | 17 | 0.0 |
Molecular Sequence Data | 96 | 0.0 |
Protein Binding | 6 | 0.0 |
Protein Structure, Tertiary | 7 | 0.0 |
RNA, Messenger/genetics/metabolism | 2 | 0.0 |
Sequence Alignment | 18 | 0.0 |
Sequence Analysis, DNA | 10 | 0.0 |
Sequence Homology, Amino Acid | 21 | 0.0 |
Antifungal Agents/*pharmacology | 11 | 22.0 |
Blotting, Northern | 8 | 0.0 |
Candidiasis, Oral/*microbiology | 2 | 33.0 |
DNA, Fungal/chemistry/genetics | 2 | 33.0 |
Drug Resistance, Microbial | 5 | 3.0 |
Fluconazole/*pharmacology | 3 | 20.0 |
Fungal Proteins/genetics | 5 | 3.0 |
Genes, Fungal/genetics | 2 | 10.0 |
Genes, MDR/genetics | 3 | 27.0 |
Genotype | 2 | 0.0 |
Microbial Sensitivity Tests | 17 | 7.0 |
Phenotype | 3 | 0.0 |
Research Support, Non-U.S. Gov't | 91 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 53 | 0.0 |
Gene Expression Regulation/immunology | 2 | 1.0 |
Gene Library | 3 | 0.0 |
Jurkat Cells | 3 | 0.0 |
Sensitivity and Specificity | 3 | 0.0 |
T-Lymphocytes/immunology/metabolism | 2 | 1.0 |
Antifungal Agents/pharmacology | 3 | 7.0 |
Base Sequence | 42 | 0.0 |
Drug Resistance, Fungal | 2 | 28.0 |
Estradiol/pharmacology | 2 | 0.0 |
Fungal Proteins/genetics/*metabolism | 2 | 3.0 |
*Gene Expression Regulation, Fungal | 3 | 7.0 |
Membrane Transport Proteins/genetics/*metabolism | 2 | 20.0 |
Promoter Regions (Genetics)/genetics | 2 | 0.0 |
Antibody Diversity | 4 | 26.0 |
Cattle | 5 | 0.0 |
Complementarity Determining Regions/*genetics | 2 | 28.0 |
DNA/genetics | 4 | 0.0 |
Fetus/*immunology | 2 | 4.0 |
Hybridomas | 3 | 2.0 |
Immunoglobulin Joining Region/genetics | 2 | 9.0 |
Immunoglobulin M/genetics | 2 | 13.0 |
Immunoglobulin Variable Region/genetics | 7 | 6.0 |
Immunoglobulins, Heavy-Chain/genetics | 11 | 6.0 |
Mice | 31 | 0.0 |
Mutation | 11 | 0.0 |
Sequence Homology, Nucleic Acid | 6 | 0.0 |
Species Specificity | 5 | 0.0 |
*Mutation | 8 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 10 | 0.0 |
Transfection | 6 | 0.0 |
Biological Transport | 4 | 0.0 |
*Fungal Proteins | 2 | 5.0 |
Saccharomyces cerevisiae/genetics | 2 | 0.0 |
Transformation, Genetic | 2 | 1.0 |
Adult | 9 | 0.0 |
Cell Differentiation | 2 | 0.0 |
DNA Primers/chemistry | 3 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
Gene Rearrangement | 3 | 0.0 |
Models, Biological | 2 | 0.0 |
Polymerase Chain Reaction | 11 | 0.0 |
Amino Acid Substitution | 3 | 0.0 |
Crystallography, X-Ray | 4 | 0.0 |
Dimerization | 2 | 0.0 |
Immunoglobulin Variable Region/*chemistry | 2 | 28.0 |
Immunoglobulins, Light-Chain/*chemistry | 2 | 50.0 |
Mutagenesis, Site-Directed | 9 | 0.0 |
Protein Conformation | 10 | 0.0 |
Protein Structure, Secondary | 3 | 0.0 |
Antibody Affinity | 5 | 2.0 |
Antibody Specificity | 8 | 0.0 |
Enzyme-Linked Immunosorbent Assay | 9 | 0.0 |
Flow Cytometry | 4 | 0.0 |
Ligands | 5 | 0.0 |
Mutation/genetics | 3 | 0.0 |
*Peptide Library | 3 | 5.0 |
Surface Plasmon Resonance | 2 | 1.0 |
Antibodies, Monoclonal | 2 | 0.0 |
Antigen Presentation | 2 | 0.0 |
B-Lymphocytes/*immunology | 2 | 0.0 |
Binding Sites, Antibody | 6 | 1.0 |
Immunoglobulin Variable Region/genetics/immunology | 2 | 10.0 |
Mice, Inbred BALB C | 6 | 0.0 |
Antibody Specificity/*genetics | 2 | 100.0 |
Peptide Library | 2 | 1.0 |
Blotting, Southern | 6 | 0.0 |
Phylogeny | 3 | 0.0 |
Immunoglobulin Variable Region/chemistry | 2 | 25.0 |
Drug Resistance, Microbial/genetics | 10 | 10.0 |
*Membrane Transport Proteins | 13 | 2.0 |
*Antibody Affinity | 2 | 11.0 |
Complementarity Determining Regions/*immunology | 2 | 100.0 |
HIV Envelope Protein gp120/*immunology | 2 | 1.0 |
Immunoglobulins, Fab/immunology | 2 | 1.0 |
Neutralization Tests | 2 | 0.0 |
Structure-Activity Relationship | 9 | 0.0 |
Rabbits | 9 | 0.0 |
Cell Line | 14 | 0.0 |
T-Lymphocytes/*immunology | 6 | 0.0 |
ATP-Binding Cassette Transporters/*genetics | 2 | 0.0 |
Candida albicans/*drug effects/*genetics/metabolism | 2 | 100.0 |
Drug Resistance, Multiple/genetics | 4 | 9.0 |
*Genes, Fungal | 4 | 3.0 |
ATP-Binding Cassette Transporters/genetics/metabolism | 4 | 14.0 |
Fluconazole/pharmacology | 3 | 21.0 |
RNA, Messenger/metabolism | 3 | 0.0 |
Clone Cells | 5 | 0.0 |
Arthritis, Rheumatoid/*immunology | 2 | 0.0 |
Binding Sites, Antibody/genetics | 2 | 15.0 |
Immunoglobulins, Light-Chain/chemistry/*immunology | 2 | 100.0 |
In Vitro | 3 | 0.0 |
Kinetics | 5 | 0.0 |
Up-Regulation | 2 | 0.0 |
Antibodies, Monoclonal/genetics/immunology | 2 | 18.0 |
Genes, Immunoglobulin/*genetics | 6 | 14.0 |
Polysaccharides, Bacterial/*immunology | 3 | 12.0 |
Candidiasis, Oral/microbiology | 4 | 50.0 |
Culture Media | 2 | 0.0 |
Amino Acids/analysis | 2 | 0.0 |
Sequence Analysis | 3 | 0.0 |
Candida albicans/*drug effects/genetics | 2 | 40.0 |
Drug Resistance, Multiple | 3 | 1.0 |
Fungal Proteins/*genetics/metabolism | 2 | 6.0 |
Genes, Fungal | 3 | 2.0 |
Antibodies, Monoclonal/*immunology | 4 | 0.0 |
Autoantibodies/*immunology | 4 | 1.0 |
Cardiolipins/immunology | 2 | 16.0 |
Cytotoxicity, Immunologic | 2 | 0.0 |
Immunoglobulin Idiotypes/*immunology | 2 | 5.0 |
Immunoglobulin Variable Region/*immunology | 2 | 10.0 |
Peptides/immunology | 5 | 3.0 |
T-Lymphocytes/immunology | 6 | 0.0 |
Cross Reactions | 4 | 0.0 |
HIV Infections/*immunology | 3 | 0.0 |
CHO Cells | 4 | 0.0 |
Glycosylation | 3 | 0.0 |
Hamsters | 4 | 0.0 |
*Immunoconjugates | 2 | 0.0 |
Protein Folding | 2 | 0.0 |
*Genes, Immunoglobulin | 13 | 6.0 |
Immunoglobulin Variable Region/chemistry/*genetics | 4 | 100.0 |
Immunoglobulin Variable Region/*genetics | 18 | 16.0 |
Immunoglobulins, Light-Chain/genetics | 5 | 14.0 |
Antigen-Antibody Reactions | 2 | 0.0 |
Genes, Immunoglobulin | 7 | 3.0 |
Child, Preschool | 3 | 0.0 |
*X Chromosome | 2 | 0.0 |
Gene Expression Regulation, Fungal | 3 | 4.0 |
Adenosine Triphosphate/metabolism | 2 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
Recombinant Proteins | 2 | 0.0 |
Histocompatibility Antigens Class II/immunology | 2 | 1.0 |
Dose-Response Relationship, Immunologic | 2 | 0.0 |
Peptide Mapping | 3 | 0.0 |
Antifungal Agents/metabolism/*pharmacology | 2 | 66.0 |
Drug Resistance, Multiple/*genetics | 2 | 3.0 |
Mice, Inbred C57BL | 3 | 0.0 |
Polymorphism, Genetic | 2 | 0.0 |
Receptors, Antigen, T-Cell, alpha-beta/*genetics | 5 | 7.0 |
*Drug Resistance, Multiple | 2 | 1.0 |
Sequence Deletion | 3 | 0.0 |
B-Lymphocytes/immunology | 3 | 0.0 |
Immunoglobulins, Heavy-Chain/*genetics | 11 | 7.0 |
Immunoglobulin Variable Region/*chemistry/genetics | 3 | 50.0 |
Immunoglobulins, Heavy-Chain/*chemistry/genetics | 2 | 50.0 |
Tumor Cells, Cultured | 3 | 0.0 |
*Genes, MDR | 2 | 5.0 |
*Conserved Sequence | 2 | 1.0 |
Receptors, Antigen, T-Cell/*immunology | 3 | 1.0 |
Codon | 3 | 0.0 |
DNA, Complementary/genetics | 2 | 0.0 |
Models, Genetic | 2 | 0.0 |
Receptors, Antigen, T-Cell, alpha-beta/*immunology | 6 | 11.0 |
Recombinant Proteins/immunology | 3 | 0.0 |
DNA Primers/genetics | 2 | 0.0 |
Lymphocyte Activation | 4 | 0.0 |
Complementarity Determining Regions/genetics | 3 | 14.0 |
Genetic Vectors | 4 | 0.0 |
Cells, Cultured | 2 | 0.0 |
Alleles | 2 | 0.0 |
Binding Sites | 6 | 0.0 |
Child | 2 | 0.0 |
Mutagenesis | 2 | 0.0 |
Restriction Mapping | 2 | 0.0 |
Epitope Mapping | 3 | 1.0 |
Immunoglobulin Variable Region/immunology | 2 | 6.0 |
Major Histocompatibility Complex | 2 | 0.0 |
Antibodies, Monoclonal/*genetics | 2 | 40.0 |
Escherichia coli/genetics | 2 | 0.0 |
Nucleic Acid Hybridization | 4 | 0.0 |
Plasmids | 3 | 0.0 |
Molecular Structure | 3 | 0.0 |
Epitopes/*immunology | 2 | 0.0 |
Gene Rearrangement, B-Lymphocyte, Heavy Chain | 2 | 3.0 |
Rats | 3 | 0.0 |
Antibodies, Anti-Idiotypic/immunology | 2 | 5.0 |
Autoantibodies/*biosynthesis | 2 | 3.0 |
*Gene Rearrangement | 2 | 0.0 |
HLA-DR Antigens/*immunology | 3 | 2.0 |
Receptors, Antigen, T-Cell, alpha-beta/chemistry/*immunology | 2 | 66.0 |
Antibodies, Monoclonal/metabolism | 2 | 0.0 |
Oligonucleotide Probes | 2 | 0.0 |
Antibodies, Antinuclear/*genetics | 3 | 50.0 |
DNA/isolation & purification | 2 | 1.0 |
Multigene Family | 2 | 0.0 |
*Polymorphism, Restriction Fragment Length | 2 | 0.0 |
Arthritis, Rheumatoid/immunology | 2 | 2.0 |
Lupus Erythematosus, Systemic/immunology | 3 | 2.0 |
Drug Resistance, Fungal/*genetics | 3 | 37.0 |
Immunoglobulins, lambda-Chain/*genetics | 2 | 12.0 |
RNA, Messenger/genetics | 3 | 0.0 |
Haemophilus influenzae/*immunology | 2 | 8.0 |
Immunoglobulins, mu-Chain/*genetics | 2 | 22.0 |
*Cloning, Molecular | 2 | 0.0 |
Immunohistochemistry | 2 | 0.0 |
